September 2022 FDA Recall Drug by Remedyrepack Inc.
D-1538-2022 - Presence of Foreign Substance

This Class II drug recall was voluntarily initiated by Remedyrepack Inc. on September 15, 2022 for the product Drug. The FDA reported the reason for recall as presence of foreign substance. The product was distributed in Distributed to two direct accounts in PA and AK. and the recall is currently terminated.

Recall Number: D-1538-2022

Reason for Recall
Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
Initiated
09-15-2022
Reported
09-21-2022
Quantity
1,699 blister cards/30 tablets each

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Distributed to two direct accounts in PA and AK.
Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00

Batch or Lot Expiration Information

Lot# J0636336-073022, J0637605-080422, Exp. date 08/31/2023